Evidence map›Paper›PMID 40160210›Full record

ArticleIn vitro models2025

A standardized in vitro bioengineered skin for penetrating wound modeling.

C Sofia Salazar Silva, Werner Petzold, Ulrike Hirsch, Christian E H Schmelzer, Andrea Friedmann

Abstract read
In one paragraph

Article in In vitro models, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

C Sofia Salazar SilvaFraunhofer Institute for Microstructure of Materials and Systems IMWS, Walter-Huelse-Strasse 1, 06120 Halle (Saale), Germany.ORCID 0009-0006-6520-6853
Werner PetzoldFraunhofer Institute for Microstructure of Materials and Systems IMWS, Walter-Huelse-Strasse 1, 06120 Halle (Saale), Germany.ORCID 0009-0006-6504-4313
Ulrike HirschFraunhofer Institute for Microstructure of Materials and Systems IMWS, Walter-Huelse-Strasse 1, 06120 Halle (Saale), Germany.ORCID 0000-0002-1123-4350
Christian E H SchmelzerFraunhofer Institute for Microstructure of Materials and Systems IMWS, Walter-Huelse-Strasse 1, 06120 Halle (Saale), Germany.ORCID 0000-0002-1180-0201
Andrea FriedmannFraunhofer Institute for Microstructure of Materials and Systems IMWS, Walter-Huelse-Strasse 1, 06120 Halle (Saale), Germany.ORCID 0000-0001-8494-1366

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Over the years, significant progress has been made in developing cost-effective and ethical in vitro bioengineered skin substitutes to study cutaneous wound healing processes. Rodents and small animal models are not optimal due to physiological differences in their skin compared to human skin. The generation of reproducible and precise wounds is key to obtaining comparable results. We created a three-dimensional skin wounding model by growing a fully differentiated, stratified squamous epithelium from human keratinocytes at an air-liquid interface on a type I collagen scaffold concealed with human dermal BJ fibroblasts. To generate the wounds, a stamp with incorporated needles with a length of 250 µm was used to puncture the epidermis to produce standardized wounds. The stamping needle technique is a practical and inexpensive method for creating length-tailored wounds on three-dimensional skin models. The effectiveness of this technique in treating 3D skin models was demonstrated, accompanied by an evaluation of the model's functionality in terms of cell proliferation, differentiation, and immunological characteristics.

Indexed as

BiomaterialsCollagenEpidermal barrierStamping needleTissue engineering

Identifiers

PMID40160210
PMCPMC11950554

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.